Document Detail

Effects of atorvastatin and atorvastatin withdrawal on soluble CD40L and adipocytokines in patients with hypercholesterolaemia.
MedLine Citation:
PMID:  16869445     Owner:  NLM     Status:  MEDLINE    
OBJECTIVE: Beyond lipid lowering, statins have pleiotropic effects with favourable benefits against atherogenesis. Withdrawal of statin therapy has been demonstrated to abrogate vascular protective activity and even increase the incidence of thrombotic vascular events. The purpose of this study is to investigate the serial changes of soluble CD40 ligand (sCD40L) and two adipocytokines, adiponectin and resistin, after short-term atorvastatin therapy and withdrawal in patients with hypercholesterolaemia. METHODS AND RESULTS: Thirty-two patients with hypercholesterolaemia received atorvastatin 10 mg/day for 3 months. Serum lipid profiles, and levels of sCD40L, adiponectin and resistin, were assessed before and immediately after 3 months' statin therapy. Serum levels of sCD40L and adiponectin were also measured on the 3 consecutive days after statin withdrawal. After 3 months' statin therapy, levels of sCD40L (1.93 +/- 1.13 vs. 1.30 +/- 0.97 ng/mL), total cholesterol and low-density lipoprotein cholesterol (LDL-C) were all reduced significantly (p < 0.05). However, sCD40L level tended to increase towards baseline on the first and second days after statin withdrawal, but was not significantly elevated until the third day after withdrawal (1.89 +/- 1.28 vs. 1.30 +/- 0.97 ng/mL, p < 0.05). Total cholesterol and LDL-C levels did not increase during the 3 days of statin withdrawal. No significant changes of adiponectin and resistin levels were shown after statin therapy. CONCLUSIONS: These results indicate that the effect of statin on sCD40L level was abrogated after therapy withdrawal, and was independent of serum cholesterol level. Statin therapy did not significantly alter levels of adiponectin and resistin.
Chih-Sheng Chu; Kun-Tai Lee; Ming-Yi Lee; Ho-Ming Su; Wen-Choi Voon; Sheng-Hsiung Sheu; Wen-Ter Lai
Related Documents :
20608995 - Effects of pravastatin and rosuvastatin on the generation of adiponectin in the viscera...
1591895 - The relation between triglyceride synthesis in peripheral tissues and postprandial plas...
10877205 - Cholesterol efflux from normal and tangier disease fibroblasts into normal, high-densit...
2344775 - The effect of cimetidine on plasma lipoproteins.
10508045 - Low plasma cefepime levels in critically ill septic patients: pharmacokinetic modeling ...
8435895 - Different modes of growth hormone (gh) administration do not change gh binding protein ...
Publication Detail:
Type:  Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Acta cardiologica     Volume:  61     ISSN:  0001-5385     ISO Abbreviation:  Acta Cardiol     Publication Date:  2006 Jun 
Date Detail:
Created Date:  2006-07-27     Completed Date:  2007-01-12     Revised Date:  2009-11-03    
Medline Journal Info:
Nlm Unique ID:  0370570     Medline TA:  Acta Cardiol     Country:  Belgium    
Other Details:
Languages:  eng     Pagination:  263-9     Citation Subset:  IM    
Division of Cardiology, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan, Republic of China.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Adiponectin / blood*
Anticholesteremic Agents / adverse effects*,  therapeutic use*
CD40 Ligand / blood*
Cholesterol / blood
Cholesterol, HDL / blood
Cholesterol, LDL / blood
Follow-Up Studies
Heptanoic Acids / adverse effects*,  therapeutic use*
Hydroxymethylglutaryl-CoA Reductase Inhibitors / adverse effects*,  therapeutic use*
Hypercholesterolemia / blood*,  drug therapy*
Middle Aged
Pyrroles / adverse effects*,  therapeutic use*
Resistin / blood*
Substance Withdrawal Syndrome / blood*
Triglycerides / blood
Reg. No./Substance:
0/Adiponectin; 0/Anticholesteremic Agents; 0/Cholesterol, HDL; 0/Cholesterol, LDL; 0/Heptanoic Acids; 0/Hydroxymethylglutaryl-CoA Reductase Inhibitors; 0/Pyrroles; 0/Resistin; 0/Triglycerides; 110862-48-1/atorvastatin; 147205-72-9/CD40 Ligand; 57-88-5/Cholesterol

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Stochastic probability modeling to predict the environmental stability of nanoparticles in aqueous s...
Next Document:  Quantitative analysis of semi-supine exercise echocardiography--influence of age on myocardial Doppl...